Actinium Pharmaceuticals Financials - Benzinga

Actinium Pharmaceuticals Inc

ATNMAMEX

Trade with Public

Trade with Public

$1.22

0.032.52%

At close: Sep 18, 5:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Actinium Pharmaceuticals Financials

Actinium Pharmaceuticals (ATNM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Actinium Pharmaceuticals Q2 EPS $0.89 Beats $(0.21) Estimate, Sales $35.000M

Actinium Pharmaceuticals (AMEX:ATNM) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of $(0.21) by 523.81 percent. This is a 504.55 percent increase over losses of $(0.22) per

Benzinga Newsdesk

PRO
Actinium Pharmaceuticals Q3 EPS $(0.37) Misses $(0.30) Estimate

Actinium Pharmaceuticals (AMEX:ATNM) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 23.33 percent. This is a 24.49 percent increase over losses of $(0.49) per

Benzinga Newsdesk

PRO
Actinium Pharmaceuticals Q2 2024 GAAP EPS $(0.38) Beats $(0.43) Estimate

Actinium Pharmaceuticals (AMEX:ATNM) reported quarterly losses of $(0.38) per share which beat the analyst consensus estimate of $(0.43) by 11.63 percent.

Benzinga Newsdesk

S&P 500 Down Over 100 Points; Actinium Pharmaceuticals Shares Plunge

Avi Kapoor

Dow Tumbles 950 Points; ISM Services PMI Surges In July

Avi Kapoor

Nasdaq Tumbles 3%; Tyson Foods Earnings Top Views

Avi Kapoor